The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis

Bone Marrow Transplant. 2008 Sep;42(6):429-30. doi: 10.1038/bmt.2008.184. Epub 2008 Jun 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Chronic Disease
  • Female
  • Graft Survival / genetics*
  • Graft vs Host Disease / enzymology
  • Graft vs Host Disease / genetics*
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Leukemia / enzymology
  • Leukemia / genetics
  • Leukemia / therapy
  • Male
  • Methotrexate / administration & dosage*
  • Methylenetetrahydrofolate Dehydrogenase (NAD+) / genetics*
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Time Factors
  • Transplantation, Homologous
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Methylenetetrahydrofolate Dehydrogenase (NAD+)
  • Methotrexate